On the matter of the Kentgrove facility, here I am equally...

On the matter of the Kentgrove facility, here I am equally confused:

1.  If this is an act of officially commissioning Kentgrove to raise capital for MSB, why is only 2 million worth of stock being issued?  Even at the last closing price of $1.43, that works out to some $2.7m.  Given MSB consumes some $25m per quarter, they are mandating Kentgrove to raise less than 1.5 weeks' worth of cash outflows.  It begs the question, why not 5 m shares?  Or 6m? Or 10m?

2.  I read the prospectus and I am a bit flummoxed as to how the process will work in this case. Seemingly, Kentgrove has a month to arrange for the capital to be raised to fund the purchase of the 2m shares, and then it has to apply - in writing - to MSB for the stock to be issued.  None of the other equity finance facilities I have encountered before have worked in this manner.   So if anyone can help me understand how this will work in a practical sense, I would appreciate it [*].

3.  Why is there no minimum price specified in the announcement?  As per the agreement between MSB and Kentgrove, MSB would specify: (1) the quantum of shares to be issued, (2) the period over which they would be issued, and (3) the minimum price at which they would be issued.  The prospectus specifies items (1) and (2) but is silent on (3).

4.  Why did this announcement coincide with the announcement of shares to be issued to a strategic consultant?  


[*] Judging from some of the strange commentary that has been posted over the past 48 hours subsequent to the announcement having been made, I sense I am no alone in not really fully understanding the mechanics of Kentgrove facility, and so I am sure there are others who might benefit from a bit of a more informed discussion about how this will actually work.